Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002688 stock hub

SHE/002688 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/002688is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.5B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/002688
In the news

Latest news · SHE/002688

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20
P25 17.1P50 24.2P75 37.8
Trailing P/E120.8
P25 23.5P50 41.3P75 83.2
ROE0
P25 -0.9P50 4.1P75 8.8
ROIC0.1
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/002688 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
235
Groups with data
11
Currency
CNY
Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
2,476
Employees Change
160%
Employees Change Percent
6.91
Enterprise value
CNY 5.7B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CNE100001HK7
Last refreshed
2026-05-10
Market cap
CNY 4.5B
Price
CNY 6
Price currency
CNY
Rev Per Employee
1,209,543.59x
Sector
Healthcare
Sic
2834
Symbol
she/002688
Website
https://www.jinhe.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
0.86%
EV Earnings
146.82x
EV/EBIT
15.61x
EV/EBITDA
9.19x
EV/FCF
60.47x
EV/Sales
1.9x
FCF yield
2.09%
Forward P/E
20x
P/B ratio
1.8x
P/E ratio
120.8x
P/S ratio
1.5x
PE Ratio10 Y
41.32x
PE Ratio3 Y
53.9x
PE Ratio5 Y
51.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
12.11%
EBITDA Margin
20.16%
FCF margin
3.14%
Gross margin
33.9%
Gross Profit
CNY 1B
Gross Profit Growth
20.78%
Gross Profit Growth Q
18.16%
Gross Profit Growth3 Y
20.89%
Gross Profit Growth5 Y
10.31%
Net Income
CNY 38.7M
Net Income Growth
-63.52%
Net Income Growth Q
21.87%
Net Income Growth Years
2%
Net Income Growth3 Y
-21.72%
Net Income Growth5 Y
-21.89%
Pretax Margin
1.89%
Profit Margin
1.29%
Profit Per Employee
CNY 15,645
Profitable Years
17
ROA
3.94
Roa5y
2.68
ROCE
9.13
ROE
0.02
Roe5y
3.37
ROIC
0.1
Roic5y
3.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

24
MetricValue
Cagr10y
-3.5%
Cagr1y
-4.46%
Cagr3y
7.83%
Cagr5y
0.89%
Div CAGR10
9.6%
Div CAGR3
0%
Div CAGR5
-16.74%
EPS Growth
-63.88
EPS Growth Q
22.36
EPS Growth Years
2
EPS Growth3 Y
-21.71
EPS Growth5 Y
-24.44
FCF Growth
-29.11%
OCF Growth
-11%
OCF Growth Q
-67.77%
OCF Growth10 Y
5%
OCF Growth3 Y
86.44%
OCF Growth5 Y
13.06%
Revenue Growth
20.94x
Revenue Growth Q
18.67x
Revenue Growth Quarters
6x
Revenue Growth Years
7x
Revenue Growth3 Y
12.03x
Revenue Growth5 Y
10.19x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
CNY 0.52
Assets
CNY 5.8B
Cash
CNY 839.2M
Current Assets
CNY 2.4B
Current Liabilities
CNY 1.8B
Debt
CNY 1.8B
Debt EBITDA
CNY 2.94
Debt Equity
CNY 0.73
Debt FCF
CNY 19.27
Equity
CNY 2.5B
Interest Coverage
2,378.5
Liabilities
CNY 3.3B
Long Term Assets
CNY 3.4B
Long Term Liabilities
CNY 1.5B
Net Cash
CNY -973M
Net Cash By Market Cap
CNY -21.62
Net Debt EBITDA
CNY 1.61
Net Debt Equity
CNY 0.39
Net Debt FCF
CNY 10.35
Tangible Book Value
CNY 1.4B
Tangible Book Value Per Share
CNY 1.81
WACC
4.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.3
Inventory Turnover
2.85
Net Working Capital
CNY 381.1M
Quick ratio
0.86
Working Capital
CNY 549.7M
Working Capital Turnover
CNY 8.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-1%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
CNY 0.1
Dividend Years
3
Dividend Yield
1.67%
Ex Div Date
2025-06-06
Last Dividend
CNY 0.1
Payout Frequency
Annual
Payout Ratio
375.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-30%
1Y total return
-4.46%
200-day SMA
6.47
3Y total return
25.37%
50-day SMA
6.01
50-day SMA vs 200-day SMA
50under200
5Y total return
4.54%
All Time High
13.28
All Time High Change
-54.82%
All Time High Date
2016-07-07
All Time Low
2.91
All Time Low Change
106.19%
All Time Low Date
2024-02-06
ATR
0.14
Beta
0.45
Beta1y
0.47
Beta2y
0.07
Ch YTD
0.84
High
6.02
High52
8.06
High52 Date
2025-08-06
High52ch
-25.56%
Low
5.97
Low52
5.56
Low52 Date
2026-03-23
Low52ch
7.91%
Ma50ch
-0.12%
Price vs 200-day SMA
-7.24%
RSI
53.08
RSI Monthly
54.24
RSI Weekly
47.16
Sharpe ratio
-0.02x
Sortino ratio
0.15
Total Return
0.66%
Tr YTD
0.84
Tr1m
-0.17%
Tr1w
-0.33%
Tr3m
-4.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 362.6M
Operating Income Growth
22.42
Operating Income Growth Q
35.22
Operating Income Growth3 Y
41.54
Operating Income Growth5 Y
9.95
Operating margin
12.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
488,637,571%
Net Borrowing
94,467,222
Shares Insiders
34.85%
Shares Institutions
6.89%
Shares Out
749,982,988
Shares Qo Q
-4.89%
Shares Yo Y
1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
CNY 94M
Average Volume
11,511,366.6x
Bv Per Share
2.97
CAPEX
CNY -335.7M
Ch10y
-41.63
Ch1m
-0.17
Ch1w
-0.33
Ch1y
-5.96
Ch3m
-4.61
Ch3y
18.34
Ch5y
-1.32
Ch6m
-4.31
Change
0.5%
Change From Open
0.5
Close
5.97
Days Gap
0
Depreciation Amortization
241,124,461
Dollar Volume
37,373,700
Earnings Date
2026-04-29
EBIT
CNY 362.6M
EBITDA
CNY 603.8M
EPS
CNY 0.05
F Score
6
FCF
CNY 94M
FCF EV Yield
1.65x
FCF Per Share
CNY 0.13
Financing CF
156,294,412
Fiscal Year End
December
Founded
1,990
Goodwill
279,921,505
Graham Number
1.8222
Graham Upside
-69.63
Income Tax
CNY 55.9M
Investing CF
-328,987,188
Is Primary Listing
1
Last Earnings Date
2026-04-29
Last Report Date
2026-03-31
Last Split Date
2016-05-17
Last Split Type
Forward
Lynch Fair Value
CNY 0.25
Lynch Upside
-95.86
Ma150
6.23
Ma150ch
-3.75%
Ma20
5.91
Ma20ch
1.57%
Net CF
251,854,801
Next Earnings Date
2026-07-31
Open
5.97
P FCF Ratio
47.85
P OCF Ratio
10.47
Payment Date
2025-06-06
Position In Range
60
Ppne
2,338,819,500
Price Date
2026-05-08
Price EBITDA
CNY 7.45
Ptbv Ratio
3.24
Relative Volume
0.54x
Revenue
2,994,829,930x
Tax By Revenue
1.87x
Tax Rate
98.99%
Tr6m
-4.31%
Volume
6,228,950
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHE/002688 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.7%
$0.10 annual per share
Payout ratio
+375.9%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-16.7%
0 consecutive years of growth
Total shareholder yield
+0.7%
Next ex-dividend date: 2025-06-06
Performance

SHE/002688 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-4.5%
S&P 500 1Y: n/a
3Y total return
+25.4%
S&P 500 3Y: n/a
5Y total return
+4.5%
S&P 500 5Y: n/a
10Y total return
-30.0%
S&P 500 10Y: n/a
Ownership

Who owns SHE/002688?

Insider, institutional, and short-interest positioning.

Institutional ownership
+6.9%
Share of float held by funds and institutions
Insider ownership
+34.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+1.0%
Negative means the company is buying back shares.
Technical

SHE/002688 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.1
Neutral momentum band
Price vs 200-day MA
-7.2%
50/200-day relationship not available
Beta (5Y)
0.45
Less volatile than the market
Sharpe ratio
-0.02
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/002688

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002688 stock rating?

she/002688 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002688 analysis?

The full report lives at /stocks/she/002688/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002688?

The latest report frames she/002688 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002688 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.